Daily Stock List
Grizzly Gold Corp. (GRZG)
Investors Alley and StreetAuthority Financial reported this month on Grizzly Gold Corp. (GRZG), Real Pennies, Terry's Tips, Weiss Research, and Trade of the Week did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Founded in 2010, Grizzly Gold Corp. is an exploration company focusing on advancing development on their gold projects in the Nevada area. The Company formerly went by the name BCS Solutions, Inc. They changed their corporate name to Grizzly Gold Corp. in August of 2011. The Company lists on the OTC Bulletin Board. Grizzly Gold has their headquarters in Reno, Nevada.
The Company's portfolio has a direct focus on the rich history and established mining infrastructure of Nevada. Grizzly Gold's LB Vixen property is in Humboldt County, Nevada in the southern Jackson Mountains. The property is approximately 150 miles northeast of Reno and 55 miles west of Winnemucca, Nevada.
LB Vixen is situated approximately 15 miles north-northeast of Allied Nevada Gold Corp.'s Hycroft gold mine. The Sleeper Mine (production and reserves of approximately 7 million ounces of gold) is situated approximately 30 miles northeast of LB Vixen. The LB Vixen property currently consists of 82 unpatented claims.
In January of 2012, the results of a geochemical rock chip sampling were compiled and posted on a topographical base map. Three areas were recognized for an initial phase of soil sampling to identify potential drill targets. In March 2012, Phase 1 of soil sampling was completed. The scope of Phase 1 covered approximately 580 acres on the property with 205 soil samples collected. Phase 2 of soil sampling began in May of 2012.
In late November 2012, Grizzly Gold announced Phase 1 drilling results on the LB Vixen property in Humboldt County, Nevada. The Company has assay results from the four Phase 1 drill holes on the LB Vixen property. All four widely spaced holes encountered gold mineralization. These demonstrate the possible existence of a large bulk tonnage, sediment hosted gold deposit on the LB Vixen property.
In January 2013, Grizzly Gold announced that they staked 100 additional claims near the original LB Vixen claim group. The Company has an option to acquire 100 percent of the rights to the mining interest of the LB/Vixen property located in Humboldt County, Nevada that originally consisted of 30 unpatented claims. The original LB/Vixen property and the additional 100 claims will now be referred to as Grizzly Gold's Fox Spring Project with 130 contiguous claims.
Grizzly Gold Corp. (GRZG), closed Tuesday's trading session at $0.742, down 2.37%, on 36,053 volume with 31 trades. The average volume for the last 60 days is 103,038 and the stock's 52-week low/high is $0.30/$1.75.
Santo Mining Corp. (SANP)
OTCPicks reported recently on Santo Mining Corp. (SANP), The Stock Detective, SuperStockHunter, Stock Market Authority, Stock Specialists, Real Pennies did earlier, and we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Santo Mining Corp. is a junior minerals exploration and development company headquartered in Santo Domingo, Dominican Republic. Their properties are strategically located in the prolific and highly prospective Hispaniola Gold-Copper Back-Arc area in the Dominican Republic. The Company combines rapid exploration methodology with innovative operational and logistical approaches to ensure the efficient and effective extraction of gold and other metals in the future. The Santo Mining claims are 100 percent owned.
The Company's vision is to define deposits and extract metals from both alluvial deposits that require minimal processing and bulk-tonnage, and open-pit oxide and sulfide gold deposits where poly-metallic ores with economic concentrations of precious and base metals may be extracted and transported to local or offshore processing plants and refineries.
Santo Mining has their Walter Mineral Claim. This two square-kilometer claim is strategically located less than one mile from the world-class Pueblo Viejo Gold Mine operated by Barrick Gold to the East and one mile to the Perilya Gold mine to the South West. Santo also has their Maria Mineral Claim – a 100 percent acquisition. They acquired 100 percent of the Maria gold exploration claim north of the city of Bonao, in the center of the Dominican Republic. This highly prospective 1,400-Hectare claim is ideally situated between three massive mineral finds.
Santo Mining acquired 100 percent of the Alexia gold exploration claim near Dajabon in the northwest Dominican Republic. This highly prospective 11,575-Hectare claim is surrounded in all directions by a number of gold discoveries under continued exploration by various mining companies.
In October 2012, Santo Mining announced that they acquired 100 percent of Gexplo SRL's rights to the Shalee gold exploration claim in the Dominican Republic. This highly prospective 42.75 square kilometer claim is within the famed Hispaniola Gold-Copper Back-Arc.
This month, Santo Mining announced that they entered into an agreement to acquire 100 percent or option the RICHARD gold exploration application (the RICHARD Claim) in the mineral-rich Hispaniola Gold-Copper Back-Arc. The RICHARD Claim is a 220-hectare claim strategically located 200 meters southwest of Barrick Gold's Pueblo Viejo mine.
In 2012 and January 2013, the Company's field exploration team conducted accelerated due diligence on the RICHARD Claim. This consisted of property wide reconnaissance surveys, including stream sediment sampling and surface soil geochemistry. The exploration team sent several batches of soil, sediment and rock samples to Acme Laboratories for multi-element trace analysis. The certified results have potentially identified two zones of gold, silver, and copper anomalies.
Santo Mining Corp. (SANP), closed Tuesday's trading session at $0.151, up 7.09%, on 67,880 volume with 36 trades. The average volume for the last 60 days is 230,559 and the stock's 52-week low/high is $0.1301/$11.00.
Bourque Industries, Inc. (BORK)
TradingAuthority Daily, StreetAuthority Daily, and TopStockAnalysts reported earlier on Bourque Industries, Inc. (BORK), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Bourque Industries, Inc. is an advanced materials science company that lists on the OTC Markets' OTC Pink Current Information. The Company develops and produces metal alloys and related product applications using their innovative Kryron metal-alloying process. Kryronized alloys have shown potential worldwide for paradigm-shifting applications across a broad spectrum of industries. These include ballistic armor, electrical, aviation, automotive, mining, medical devices, agriculture & heavy equipment, consumer electronics, and others. Bourque Industries has their headquarters in Tucson, Arizona.
The Company is a development stage enterprise. They are in the process of commercializing their patented Kryron metal-alloying process using nanotechnology to alter, fundamentally, common metals at the molecular level to create ultra-high performing super alloys.
Bourque Industries conducts R&D to optimize Kryron alloys for specific applications, produces and manufactures Kryron alloys and specific product applications to the highest quality standards, and develops marketing programs and strategies to penetrate industrial markets around the world with Kryron alloys. In addition, they manage strategic partnerships, acquisitions, and product development to provide ancillary or complimentary products, systems and technology to further the use of Kryron alloys and products worldwide.
Earlier this month, Bourque Industries announced their first LED purchase order for US$252,000 from Shenzhen JBT Electronics Technology Co., Ltd. (JBT) for Kryronized aluminum. This is for use in the LED Heat Sink lighting industry. In JBT Electronics' testing so far, they found that the Kryron metal provided for testing was able to provide sufficient heat dissipation within just 14 square centimeters for each watt of LED power (considering only LED lights of 10 watts or more). This is greater than a 60 percent reduction in the size requirement of heat sinks cooling LED lights, currently. JBT Electronics is a high technology LED company in Guangdong, China.
In addition, earlier this month, Bourque Industries announced a restructuring and expansion of the Company's Board of Directors and the appointment of a new interim Chief Executive Officer.
The Board of Directors expanded from three to five seats. Mr. Sean Floyd was elevated to Chief Executive Officer, and Mr. John Bourque, the Founder of the Company and the inventor of their technology, was repositioned as Chief Scientist.
Bourque Industries, Inc. (BORK), closed Tuesday's trading session at $0.0935, down 6.50%, on 509,157 volume with 27 trades. The average volume for the last 60 days is 1,342,110 and the stock's 52-week low/high is $0.0082/$0.77.
Diamcor Mining, Inc. (DMIFF)
We are reporting on Diamcor Mining, Inc. (DMIFF), here at the QualityStocks Daily Newsletter.
Diamcor Mining, Inc. is a production-focused company that lists on the OTCQX International. The Company has a proven operational history as a supplier of rough diamonds to the global market. In March 2011, they established a long-term strategic alliance with luxury retailer Tiffany & Co. Diamcor Mining is now in the final stages of developing the near-term production capable "Krone-Endora at Venetia Project". They acquired Krone-Endora from DeBeers in February 2011. Diamcor Mining is based in Kelowna, British Columbia.
The Company focuses on the identification, acquisition, and operation of near-term production based diamond projects that have the potential to generate sustained rough diamond production and cash flow. Diamcor Mining's experienced operational team is in Kimberley, South Africa. This team has established relationships with diamond majors and they manage projects from inception through to operating on a 24/7 basis.
Currently, the Company is working to increase past production levels from approximately 2,000 carats per month to approximately 7,000 - 10,000 carats per month. In addition, they are targeting further growth through the identification of additional potential resources at their Krone-Endora at Venetia project, and by way of their ongoing discussions to acquire other near-term production assets with the potential to allow them to achieve targeted aggregate production levels of 25,000 - 35,000 carats per month in the next few years.
The Krone-Endora at Venetia project is directly next to the third largest diamond mine in the world, Venetia (9.0M carats/year - 2007). The deposit at Krone-Endora at Venetia has undergone identification as being a rare, and higher-grade, "eluvial" shift of material from the higher ground of Venetia onto the lower properties of Krone and Endora, and a more modern "alluvial" deposit for the upper gravels. An NI 43-101 report released in July of 2009 provided initial inferred estimates of 54,000,000 tons of diamondiferous gravel and 1,300,000 carats on the areas of the project that have been currently reviewed.
On November 27, 2012, Diamcor Mining announced the initial tender and sale of 3,579.58 carats of rough diamonds for total gross proceeds of $510,829.00 (US), or (US) $142.71 per carat on average, from their Krone-Endora at Venetia Project. The initial rough diamonds sold were recovered in tandem with the previously announced ongoing testing and commissioning exercises underway. The vast majority were from the recovery, screening, and processing of material only in the +1.0mm to -10mm size fractions of the lower-grade surface to 10 meter depths of the K1 area of the Project.
Diamcor Mining, Inc. (DMIFF), closed Tuesday's trading session at $1.48, up 2.78%, on 500 volume with 1 trade. The average volume for the last 60 days is 7,452 and the stock's 52-week low/high is $0.598/$1.696.
Jones Soda Co. (JSDA)
SmarTrend Newsletters, Investor Update, TopStockAnalysts, Dividend Opportunities, FNNO Newsletters, OTCPicks, and PennyTrader Publisher reported earlier on Jones Soda Co. (JSDA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Jones Soda Co. markets and distributes premium beverages and sells via their distribution network in markets mainly across North America. The Company is a leader in the premium soda category. Jones Soda sells through traditional beverage retailers. The Company's shares list on the OTC Markets' OTCQB. Jones Soda has their corporate headquarters in Seattle, Washington.
The Company offers a variety of flavors and the highest quality ingredients (including pure cane sugar). Their products feature a unique labeling technique that incorporates always-changing photos sent in from their customers.
Currently, the Company's beverages consist of Jones Soda, a premium carbonated soft drink, and Jones Zilch, with zero calories. Jones Zilch is an extension of the Jones Soda product line. Their beverages also include WhoopAss Energy Drink, which is an energy supplement drink, as well as WhoopAss Zero Energy Drink, with zero sugar. This product is an extension of the WhoopAss Energy Drink product line.
Jones Soda products sell in 50 states in the United States and in nine provinces in Canada. In addition, the Company sells an assortment of products on-line, which they refer to as their interactive channel. This includes soda with customized labels, wearables, candy as well as other items.
The Company's business strategy focuses on expanding points of distribution of Jones Soda in their core geographic regions in grocery, convenience and gas (C&G), and independent accounts in the U.S. and Canada. Their strategy also focuses on expanding the stock-keeping unit (SKU) offerings and space in the grocery stores where the Company is already present. Furthermore, their strategy includes developing innovative beverage brands that will allow the Company to capture market share in the growing natural carbonated drink segment.
Moreover, Jones Soda, in limited circumstances, sells concentrate for distribution or production of their products. The Company does not directly manufacture their products. They outsource the manufacturing process to third-party contract manufacturers.
Jones Soda Co. (JSDA), closed Tuesday's trading session at $0.26, up 4.00%, on 68,278 volume with 27 trades. The average volume for the last 60 days is 142,891 and the stock's 52-week low/high is $0.2315/$0.35.
Seanergy Maritime Holdings Corp. (SHIP)
Wallstreetlivechat, AwesomeStocks, and Chatter Box Stocks reported recently on Cyber Kiosk Solutions, Inc. (SHIP), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
A Marshall Islands corporation, Seanergy Maritime Holdings Corp. engages in the transportation of dry bulk cargoes through the ownership and operation of dry bulk carriers. The Company formerly went by the name Seanergy Maritime Corp. They changed their name to Seanergy Maritime Holdings Corp. in January of 2009. Founded in 2008, the Company has their corporate headquarters in Athens, Greece. Seanergy Maritime Holdings lists on the NASDAQ Capital Market.
The Company's fleet includes the Bremen Max (Panamax) - 73,503 Dead Weight Tonnage (DWT) built in 1993, and the Hamburg Max (Panamax) - 73,498 DWT, built in 1994. Their fleet also includes the Davakis G. (Supramax) - 54,051 DWT – 2008, and the Delos Ranger (Supramax) - 54,057 DWT – 2008.
Their Handysize fleet includes the African Oryx - 24,112 DWT – 1997; the African Joy - 26,482 DWT – 1996; the African Glory - 24,252 DWT – 1998, as well as the Asian Grace – 20,412 DWT – 1999.
Seanergy Maritime Holdings' fleet carries a variety of dry bulk commodities. These commodities include coal, iron ore, and grains, as well as bauxite, phosphate, fertilizer, and steel products.
At the end of January 2013, Seanergy Maritime Holdings announced that their wholly owned subsidiary, Maritime Capital Shipping Ltd., sold their 100 percent ownership interest in four subsidiaries. The four subsidiaries own the Handysize dry bulk carriers M/V Fiesta, M/V Pacific Fantasy, M/V Pacific Fighter and M/V Clipper Freeway. The buyer is a third-party nominee of the lenders under the senior secured credit facility with DVB Merchant Bank (Asia) Ltd., as agent. Maritime Capital Shipping had provided a guarantee under this facility.
Following this transaction, Seanergy Maritime Holdings' fleet consists of eight dry bulk carriers (two Panamax, two Supramax, and four Handysize vessels) with a total carrying capacity of approximately 350,367 dwt and the average age is reduced to 13.2 years, from 13.9 years previously.
Cyber Kiosk Solutions, Inc. (SHIP), closed Tuesday's trading session at $2.01, even for the day, on 3,500 volume with 12 trades. The average volume for the last 60 days is 21,057 and the stock's 52-week low/high is $1.03/$2.7099.
Dios Exploration, Inc. (DOS.V)
We are highlighting Sollensys Corp. (DOS.V) today, here at the QualityStocks Daily Newsletter.
Dios Exploration, Inc. is a leading mineral research company with corporate headquarters in Montreal, Quebec. The Company generates their own geological research opportunities. Dios is part of the Industrial Metals & Minerals industry in the Basic Materials sector. A mineral research enterprise, they operate as a mining exploration and evaluation company in Canada focusing on exploring gold, uranium, diamonds, and a carbonatite with rare earth and niobium metals. Dios Exploration lists on the TSX Venture Exchange.
The Company's strategy is to generate exploration projects from the scientific concept to feasibility and develop them alone or via joint venture (JV). Dios Exploration explores in glacial terrains; they systematically sample glacial sediment cover for minerals. Dios has 5,300 mining claims covering more than 2,750 sq. kilometers in significant areas of central Quebec and the Otish Mountains. These claims have high potential in gold and diamonds.
Dios Exploration has also discovered an alkaline complex with rare earth and niobium potential. The Company's current properties are AU33 WEST (gold), Shadow (gold-diamonds), Le Caron (gold), Shipshaw alkaline complex (niobium-tantalum-rare earths), Hotish property (IOCG- Iron Oxides Copper Gold), 33 Carats (gold-diamond), 14 Karats (Gold-Diamond), and Pontax (diamond).
This month, Dios Exploration announced that regional 2012 & 2011 till sampling programs (54 & 69 glacial sand samples) yielded over 1 gram per ton gold in till. Results include 1010 parts per billion gold (ppb Au), 836 ppb Au, 642 ppb Au, Au, 583 ppb Au, 454 ppb Au, 356 ppb Au, 160 ppb Au, 151 ppb Au, 131 ppb Au, 120 ppb Au, 115 ppb Au, 113 ppb Au, 109 ppb Au (in heavy mineral concentrates) on the Company's 14 Karats project.
The Company's 14 Karats project consists of 525 claims for 273 sq. kilometers near the Leran-Patamisk Lake area, approximately 35-55 kilometers east of the Renard diamond deposit, and 50-75 km NE of the Eastmain gold mine and the 33 Carats Gold Porphyry tonalite discovered by Dios.
Sollensys Corp. (DOS.V), closed Tuesday's trading session at $0.13, even for the day. The stock's 52-week low/high is $0.07/$0.29.
E-Waste Systems, Inc. (EWSI)
First Penny Picks and Elite Traders reported this month on E-Waste Systems, Inc. (EWSI), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in London, England, E-Waste Systems, Inc. is an electronic waste management and reverse logistics services firm. They formed to create a market-leading, integrated business in the emerging waste electrical and electronics equipment (WEEE) industry. They target businesses facing regulatory or other mandates for handling e-waste. The Company's plan is to acquire a select number of high-quality companies with strong management teams that have a shared commitment to helping customers achieve cost effective and environmentally responsible compliance with e-waste recycling and disposal requirements.
E-Waste Systems will leverage and extend their acquisitions' established customer relationships through expanding the services offered to customers, applying best practices in professional management, and by investing in modern recycling technology. They base their categories of e-waste on the WEEE Directive categories; they operate a zero-landfill objective. The Company has advanced state-of-the-art processes to achieve maximum extraction of materials to produce new manufacturing input.
For E-Waste Recycling, they offer multi-national WEEE-Directive standards of recycling and secure asset recovery and end of life management services. These include management of a client's returns, refurbishment of still useful items, re-use/resale, and complete recycling services. They recycle entire ranges of electronic waste including small domestic appliances to computer equipment, televisions to medical equipment, and electronic toys to electronic tools. They operate with a zero-landfill objective and provide certificates of data destruction with access to visual evidence of the processing.
E-Waste Systems started a new division of E-Waste Systems as a vital step in the execution of the fair-trade e-waste program. Under this program, end-of life electronics sourced in either the U.S. or Mexico can undergo processing via a highly compliant partner network of facilities with access to up to 500,000 square feet of space located primarily in Texas, California and northern Mexico.
E-Waste Systems has acquired Tech Disposal, Inc. Tech Disposal is an electronic waste recycler and asset recovery specialist based in Columbus, Ohio. Earlier this month, E-Waste Systems announced that they opened their first China office in Shanghai. The new office for the Company will be in the Golden Finance Tower, in the historic Bund district of Shanghai.
In addition, this month, the Company announced the signing of a definitive Master License agreement for China. It includes an agreement for an investment into E-Waste Systems. The initial value of the deal is worth $800,000, plus royalties and a minimum $5,000,000 sales commitment. In addition to the license agreement, the deal includes an investment of $650,000 in the Company, through a new common share issuance at $0.08/share.
E-Waste Systems, Inc. (EWSI), closed Tuesday's trading session at $0.016, even for the day, on 854,600 volume with 25 trades. The average volume for the last 60 days is 675,513 and the stock's 52-week low/high is $0.0026/$0.047.
Consorteum Holdings, Inc. (CSRH)
The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH). Today, Consorteum Holdings, Inc. closed trading at $0.03, up 22.45%, on 267,014 volume with 12 trades. The stock’s average daily volume over the past 60 days is 167,515, and its 52-week low/high is $0.001/$0.032.
Consorteum Holdings, Inc. (CSRH) utilizes the most technically advanced global solutions available today. By working with a multitude of global technologies, Consorteum is able to create customized programs for maximum results. This approach enables unparalleled flexibility when sourcing solutions, resulting in smarter, faster deployment of technologies, competitive pricing, and potential for new streams of revenue.
Through its exclusive software license with Tarsin Inc., the company leverages a team of software developers that understands the complexities of delivering digital media content across mobile handsets. Tarsin is capable of providing clients with integration and support for over 700 mobile carriers globally on a seamless and secure platform to take advantage of the increasing demand for rich mobile content.
Consorteum's flagship CAPSA technology platform brings a universal solution to the problems of wagering and betting on mobile devices. Multiple different operating systems, user interfaces, and form factors have created enormous barriers to launching commercial initiatives. But with CAPSA, gaming operators can now cost-effectively monetize innovative mobile wagering products and services quickly and robustly.
In addition to its mobile initiatives, Consorteum is also actively engaged in the financial industry, providing MasterCard solutions as well as loyalty and reward programs. The company has strategically designed its business initiatives to create repetitive transactions on an ongoing basis. Consorteum's goal is to have their customers think of them more as partners, rather than just technology providers, for longer-lasting, more profitable relationships. Disclaimer
Consorteum Holdings, Inc. Company Blog
Consorteum Holdings, Inc. News:
Consorteum Holdings Inc. Reaches Funding Agreement With Private Equity Group
Consorteum Holdings Files Form 10-K Report With the Securities and Exchange Commission
CORRECTION -- Tarsin, a Leader in Secure Mobile Platform Technology, Forges New Frontiers in Mobile Gaming
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.34, up 4.62%, on 97,865 volume with 28 trades. The stock’s average daily volume over the past 60 days is 214,984, and its 52-week low/high is $0.161/$0.65.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Strengthens Intellectual Property Portfolio
International Stem Cell Corporation Demonstrates Positive Animal Efficacy Results in Metabolic Liver Disease Program
International Stem Cell Corporation Announces Positive Results From In Vivo Animal Study of Parkinson's Disease
GlobalWise Investments, Inc. (GWIV)
The QualityStocks Daily Newsletter would like to spotlight GlobalWise Investments, Inc. (GWIV). Today, GlobalWise Investments, Inc. closed trading at $0.25, up 8.70%, on 33,600 volume with 4 trade. The stock’s average daily volume over the past 60 days is 12,620, and its 52-week low/high is $0.18/$1.87.
GlobalWise Investments, Inc. (GWIV), via wholly-owned subsidiary Intellinetics, Inc., is a leading-edge technology company focused on Enterprise Content Management (ECM) solutions for the digital age. The ECM industry continues to grow rapidly as a result of unrestricted proliferation of digital content within today's business environment. Leveraging its proprietary cloud-based computing software, GlobalWise is poised to capture a significant market share of this burgeoning industry.
GlobalWise's ECM service is delivered to customers via five unique delivery models which cover the spectrum of business needs: Cloud/Saas (Software as a Service), Hardware Vendor Integrated Service, Software Vendor Integrated Service, Premise (Client-Server), Hybrid (Premise & Cloud/Saas).This diversity gives advanced security & privacy features with an on-demand structure needed for large Tier 3 and Tier 4 businesses that are currently underserved by the market.
The Intellinetics platform defines a new industry benchmark and game-changing approach by combining advanced virtualization & automated content management with an open and service-oriented architecture using web services. The company provides strategies, tactics, and technologies used to manage paper and digital assets from capture to long-term archive, without the need for manual processes conducted by a full time employee.
GlobalWise's management boasts a combined total of over 60 years in ECM leadership and industry experience. The ECM industry is expected to exceed $5.1 billion by 2013 with Gartner predicting a compound annual growth rate of 9.5%. IBM Market Insights predicts adoption of cloud computing to grow by 26% CAGR between 2010 through 2013. Leveraging management and key department heads, Intellinetics has a strong foundation from which to capture significant market share within the lucrative $149 billion Business Software & Services industry. Disclaimer
GlobalWise Investments Company Blog
GlobalWise Investments News:
GlobalWise Comments on Recent Balance Sheet Improvements, Channel Partners and Market Opportunities
GlobalWise CEO to Speak at Technology United Executive Conference
GlobalWise Launching Sales Campaign With Public Safety Market Leader Tiburon
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.6499, up 8.32%, on 2,500 volume with 1 trade. The stock’s average daily volume over the past 60 days is 2,182, and its 52-week low/high is $0.06/$3.10.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen's Collaborators Identify Definitive Precursor for Adult Blood and the Immune System
Vistagen Therapeutics Successfully Completes Final Phase 1 Safety Study of AV-101
VistaGen Therapeutics to Present at Noble Financial Capital Markets Ninth Annual Equity Conference
Few things in medical history have been so frustrating as the seemingly endless war against cancer. Huge amounts of money, together with some of the best minds in the world, have been pitted against the disease (actually diseases, since there are many types of cancer with fundamentally different characteristics), and yet progress, though undeniable, has been maddeningly slow. Now, almost suddenly, there are serious indications that it’s a new ballgame, and that cancer has a rapidly dimming future.
Advaxis, a New Jersey based biotechnology company developing the latest drugs for various cancers and infectious diseases, is helping to lead the charge in what could become one of the biggest developments in modern medicine, immunotherapy. Unlike chemotherapy, which uses chemical poisons to kill cancer cells, poisons which are indiscriminate enough to kill many healthy cells as well, immunotherapy uses advanced biological technologies to manipulate the body’s natural immune system, making it able to both identify and attack cancer or other diseased cells with minimal damage to healthy cells.
It’s an exciting idea that has been around for a long time, but only now have the technologies developed to the point that proven drugs are starting to be released. It’s the first dribble in what could soon become a flood, as the various issues common to any new medical technology are finally worked out. The initial industry bumps in the road are rapidly being smoothed, and government approvals are finally being awarded. Why so long?
The answer is that, in order to attack cancer, it required a totally new in-depth understanding of, and ability to deal with, the internal workings of the human cell. Without this understanding, treatments could consist only of roughly tuned attacks on masses of cells that often resulted in the death of many healthy cells while many cancer cells remained alive to grow back later. This new understanding has taken decades of trial and error work to put together, time during which real treatments were not forthcoming. An entire industry of technologies had to first be developed to lay the foundation upon which modern therapies, like immunotherapy, are built. Now, at last, the final stages are being constructed, and new therapies are coming to the front. Work remains, but, thanks to companies like Advaxis, the long fight against cancer is finally turning.
For additional information, visit www.Advaxis.com
Tara Minerals Corp. is an exploration-stage company that currently has total ownership in more than 39 square miles in the Don Roman district, which is located in the northern part of the La Reforma Mining District of northeastern Sinaloa State, Mexico. The company’s current focus is on prioritizing and delineating more than 70 Don Roman gold, silver, zinc, and lead mineralized structures for production this year.
Tara’s management is focused on creating long-term shareholder value and deploying capital for the advancement of its projects. The company aims to achieve this by enhancing resources, further outlining new discoveries and targets, and acquiring additional strategic assets.
This month, Tara reported that it has begun working towards implementing the Don Roman Mine & Mill Production Plan. Geological work – including survey continuation, detailed mapping, sampling, and startup mine location work – is being conducted under the management of Chief Geologist Steve Eady. The company has also begun mill site upgrade work, including water well sourcing, process circuit optimization, maintenance and refurbishment of equipment, and installation of additional staff housing and offices. Senior Mining and Plant Engineer Tom Claridge will manage all mill site work.
Currently, Tara has the capacity to produce gold, silver, zinc, and lead at its Don Roman mill, which comprises three parallel circuits with 120 t/d capacity each. Engineering work is being done to expand capacity to 2,000+ t/d. Numerous mineralized veins have been identified in past results – some of which have averaged grades of 309 grams per tonne of silver, 9 percent zinc, and 3 percent lead. The company has cash on hand to fund an aggressive, district-wide work program to define these structures and advance them to production.
Southeast of the Don Roman mill about 1.5 kms, a significant gold and silver quartz vein has been discovered. Channel samples returned an average grade of 10.06 grams per tonne of gold and 149.85 grams per tonne of silver. This structure has a known strike length of around 850 meters as well as an exposed vertical height of around 400 meters. The vein remains open along strike and at depth.
To fund the pursuit of commercial production at Don Roman, as well as to aggressively expand production or acquire near-production projects, Tara has sold its Picacho Gold/Silver project to Yamana Gold for $35.6 million. Yamana made an initial payment of $7.5 million at closing, and a second payment of $9.8 million is due in May. Yamana will additionally pay an added $1 million for every 100,000 ounces defined by the 60-month anniversary, and the company will make a final installment payment of $4.3 million to Tara on the sixth-year anniversary. Payments for the measured, indicated, and inferred ounces that have been defined will cap off at $14 million. Yamana will make an advance payment of $3 million if no gold is defined on the property by the 36-month anniversary.
Tara is positioned for low-risk value creation through its early recognition of value and its strategy of reducing risk through a foundation of cash flow. The company continues actively pursuing future growth opportunities through the acquisition of additional exploration, development, and production assets. Due to its established office and relationships in Mexico, Tara is well positioned to acquire additional opportunities there.
For more information, visit www.TaraMinerals.com
EXFO, a leading provider of next-generation test and service assurance solutions for wireline and wireless network operators and equipment manufacturers, yesterday announced the addition of packet synchronization testing functionalities to its NetBlazer 2.0 series. This capability expansion includes performance assessment of SyncE and precision time protocol (IEEE 1588v2), giving field technicians the capability to validate sync services during Ethernet backhaul turn-ups.
Operators can no longer rely on traditional synchronization technologies because the penetration and prevalence of LTE networks and packet-based backhaul results in a significant change of synchronization distribution throughout the network. Precision time protocol/1588 and all other new packet based synchronization technologies have caused a broad array of new challenges concerning the validation and troubleshooting processes of synchronization performance because these services are very sensitive to basic network impairments. If these impairments are left unchecked, serious consequences, such as lost data and dropped calls can precipitate.
Packet-based synchronization technologies are also used to synchronize small cells. This is a critical functionality as mobile network operators rely progressively more on small cells to effectively manage the LTE-advanced spectrum, while expanding their service coverage and increasing network capacity. In order to be successful in the future, most network operators will require the ability to turn up, validate, and troubleshoot packet-based services quicker and more accurately than ever before, as the number of small cells shipped annually swells to five million by 2017.
Thanks to its added synchronization testing functionalities, the NetBlazer 2.0 series now provides operators with such flexibility and adaptability to overcome their cell-site deployment challenges. And combined with the SyncWatch-110 Synchronization Test Unit, it makes for a complete packet-synchronization testing and monitoring solution that delivers detailed and accurate sync validation throughout the network lifecycle.
“With the proliferation of LTE networks, small cells and Ethernet backhaul links, packet-synchronization validation is becoming a major concern for operators. Being able to test and troubleshoot all these services with one comprehensive tool gives them the flexibility to adapt their operational processes and make their field teams as efficient as possible,” said Étienne Gagnon, Vice-President of EXFO’s Test and Measurement Division.
For further information, visit www.EXFO.com
NewLead Holdings, the name behind the recognized international shipping fleet of dry bulk carriers used to move primarily iron ore, coal, and other dry bulk commodities, as well as double-hulled product tankers used for transporting oil, reported inking of a 1.48M metric ton steam coal supply and delivery agreement today, valued at roughly $148M in revenue over the life of the contract.
This contract is bread and butter for NEWL and will kick off in March with the initial 130k metric ton delivery, to be followed by subsequent deliveries of 150k metric tons each month from April till the close of the year (10% variation on tonnage). Given market price for steam coal at the time of the deal’s signing and mounting demand from emerging markets, the contract represents one of what are likely to be many more such lucrative shipping deals for NEWL.
The company plans to use in-house vessels or charter new ones from the market to accommodate this large deal and NEWL has put together a shrewd strategy for growing overall market share in the sector, while digging their feet in further here. The idea of reinforcing the revenue model’s foundation with ample supply inputs makes perfect sense and the resulting profitability metrics for the overall business should make investors beam, as NEWL is working on building a self-contained profit loop here.
In conjunction with this announcement, the company is also reporting an extension agreement for the previously announced acquisitions (Jan 17) on properties representing some 161.7M estimated tons of coal reserves, which will help feed this and future shipping/supply contracts. NEWL has entered an agreement to extend the timeframe for obtaining title and mineral excavation rights on the 5k acres in Kentucky, as well as ownership and leasehold interests for the 18,335 acres in Tennessee, to March 5th of this year, in order to provide time to fully finance the planned work at the mines.
Chairman, President and CEO of NWL, Michael Zolotas, spoke of the milestone integration of the company’s commodity and transport segments this announcement represents and assured shareholders that locking down both a sizeable, profitable supply contract and the means to furnish the supply itself, again at a handsome profit, would translate directly into bottom line returns they can feel. Zolotas was keen to note the creditworthiness of the buyer and tempted investors to take a closer look at the vertically integrated commodities/shipping model NEWL has assembled, underscoring the revenue generation potential and rock-solid future of the relevant sectors, while strongly suggesting this configuration represents a significant edge over competitors.
For more information on NewLead Holdings, visit www.NewLeadHoldings.com
Today's Top 3
Stock Shock and Awe
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Chairman and CEO Featured in Exclusive SmallCapVoice Interview
- Bergamo Acquisition Corp. (BGMO) Provides Authenticated Documentation to Confirm Bank Deposits
- Consorteum Holdings, Inc. (CSRH) Reaches Funding Agreement With Private Equity Group
- Cardium Therapeutics, Inc. (CXM) Announces Presentation at The 2013 Cell & Gene Therapy Forum
- Duma Energy Corp. (DUMA) Receives 1.1 Billion Barrel P10 Estimate for Namibia Concession
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- HII Technologies, Inc. (HIIT) Announces Engagement of QualityStocks Investor Relations Services
- International Stem Cell Corp. (ISCO) Strengthens Intellectual Property Portfolio
- Loans4Less.com, Inc. (LFLS) Engages CPA Firm to Audit Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Receives General License for Pharmaceutical Products Starts Mfg. 3 New Products
- Rainbow Coral Corp. (RBCC) Retains New IR Group to Optimize Investor Outreach, Relay Key Growth Plans
- TNI BioTech Inc. (TNIB) Secures Exclusive License to Portfolio of Cancer Treatment and Prevention-Related IP
- Viaspace, Inc. (VSPC) 25 Acres of Giant King Grass Shipped and Growing in St. Croix
- Viscount Systems, Inc. (VSYS) Awarded Contract to Secure Additional U.S. Government Facilities
- VistaGen Therapeutics, Inc. (VSTA) Becomes Member of Centre for Commercialization of Regenerative Medicine Consortium